Evidence for multiple sequences and factors involved in c-myc RNA stability during amphibian oogenesis.
To investigate the molecular mechanisms regulating c-myc RNA stability during late amphibian oogenesis, a heterologous system was used in which synthetic Xenopus laevis c-myc transcripts, progressively deleted from their 3' end, were injected into the cytoplasm of two different host axolotl (Ambystoma mexicanum) cells: stage VI oocytes and progesterone-matured oocytes (unfertilized eggs; UFE). This in vivo strategy allowed the behavior of the exogenous c-myc transcripts to be followed and different regions involved in the stability of each intermediate deleted molecule to be identified. Interestingly, these specific regions differ in the two cellular contexts. In oocytes, two stabilizing regions are located in the 3' untranslated region (UTR) and two in the coding sequence (exons II and III) of the RNA. In UFE, the stabilizing regions correspond to the first part of the 3' UTR and to the first part of exon II. However, in UFE, the majority of synthetic transcripts are degraded. This degradation is a consequence of nuclear factors delivered after germinal vesicle breakdown and specifically acting on targeted regions of the RNA. To test the direct implication of these nuclear factors in c-myc RNA degradation, an in vitro system was set up using axolotl germinal vesicle extracts that mimic the in vivo results and confirm the existence of specific destabilizing factors. In vitro analysis revealed that two populations of nuclear molecules are implicated: one of 4.4-5S (50-65 kDa) and the second of 5.4-6S (90-110 kDa). These degrading nuclear factors act preferentially on the coding region of the c-myc RNA and appear to be conserved between axolotl and Xenopus. Thus, this experimental approach has allowed the identification of specific stabilizing sequences in c-myc RNA and the temporal identification of the different factors (cytoplasmic and/or nuclear) involved in post-transcriptional regulation of this RNA during oogenesis.
Lefresne
J
J
Laboratoire d'Oncologie Cellulaire et de Toxicologie Génétique, Centre Anti Cancèreux, Université de Caen, 14021 Caen Cedex, France.
Lemaitre
J M
JM
Selo
M
M
Goussard
J
J
Mouton
C
C
Andeol
Y
Y
D000557:Ambystoma / Q000235:genetics / Q000502:physiology*; D000818:Animals; D016259:Genes, myc; D007700:Kinetics; D009687:Nuclear Proteins / Q000378:metabolism / Q000502:physiology; D009866:Oogenesis; D012333:RNA, Messenger / Q000235:genetics*; D014982:Xenopus laevis / Q000235:genetics / Q000502:physiology*
D009687:Nuclear Proteins; D012333:RNA, Messenger